Incyte to Report 2018 Third Quarter Financial Results

Published: Oct 11, 2018

Oct. 11, 2018 12:00 UTC

WILMINGTON, Del.--(BUSINESS WIRE)-- Incyte Corporation (Nasdaq:INCY) announced today that it has scheduled its third quarter 2018 financial results conference call and webcast for 8:00 a.m. ET on Tuesday, October 30, 2018.

The schedule for the press release and conference call/webcast is as follows:

               
   

 

Q3 2018 Press Release:

    October 30, 2018 at 7:00 a.m. ET
   

 

Q3 2018 Conference Call:

    October 30, 2018 at 8:00 a.m. ET
   

 

Domestic Dial-In Number:

    877-407-3042
   

 

International Dial-In Number:

    201-389-0864
   

 

Conference ID Number:

    13683637
   

 

         

If you are unable to participate, a replay of the conference call will be available for thirty days. The replay dial-in number for the U.S. is 877-660-6853 and the dial-in number for international callers is 201-612-7415. To access the replay you will need the conference ID number 13683637.

The live webcast with slides can be accessed at www.incyte.com under For Investors, Events and Presentations and will be available for replay for 30 days.

About Incyte

Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit the Company's website at www.incyte.com.

Follow @Incyte on Twitter at https://twitter.com/Incyte.

 

Contacts

Incyte Corporation
Investors
Michael Booth, DPhil, +1 302-498-5914
mbooth@incyte.com
or
Media
Catalina Loveman, +1 302-498-6171
cloveman@incyte.com

 

 
 

Source: Incyte Corporation

Back to news